Careers

Learn more

Qualified professionals

Learn more

Trainee & intern programmes

Learn more

Offices

New York

Learn more

San Francisco

Learn more
A&L Goodbody logo

Hospitals & Healthcare

  • Article

    Safeguarding Europe’s medicine supply – the Critical Medicines Act

    In this article, we discuss the European Commission’s (EC) proposed Critical Medicines Act (CMA), published on 11 March 2025 which aims to improve the availability, supply and production of critical medicines within the European Union (the EU).

    Hospitals & Healthcare
  • article

    Explicit consent required to use personal data for health research purposes

    New Regulations require organisations to obtain an individual’s explicit consent in advance of processing personal data for health research purposes. 

    Technology
  • article

    How female entrepreneurs can overcome key challenges – top 5 tips

    The challenges faced by female entrepreneurs need to be proactively addressed to create conditions conducive to scaling their businesses

    Commercial Contracts
  • Article

    How to prepare for the new EU General Data Protection Regulation in the Healthcare sector

    The General Data Protection Regulations (GDPR) will come into force on 25 May 2018. All Hospitals, Healthcare Organisations (HCOs) and Healthcare Practitioners (HCPs), as data controllers and processors must comply with the new law by this date. Cliona Christle, joint Head of the Firm’s Life Sciences and Healthcare Group highlights,, some of the main changes and obligations for organisations as da

    GDPR
  • Article

    Regulatory Enforcement Power of Ireland’s Health Products Regulatory Authority

    HPRA regularly carries out announced and unannounced inspections (Dawn Raids) and audits to establish and monitor industry’s compliance with relevant legislation and guidelines. This note highlights the key inspection and enforcement powers available to HPRA.

    Hospitals & Healthcare
  • Article

    Transfers of Value go public on 1 July 2016

    All Transfers of Value (ToV) from 2015 must be disclosed publicly via the Irish Pharmaceutical Healthcare Association (IPHA) central reporting system by 1 July 2016. This relates to all ToVs that were made by pharmaceutical companies to Healthcare Providers (HCPs) and Healthcare Organisations (HCOs) in connection with the development and sale of prescription only medicinal products for human use.

    Hospitals & Healthcare